ArticleMolecules (Basel, Switzerland)2019

Investigation of Metal-Organic Framework-5 (MOF-5) as an Antitumor Drug Oridonin Sustained Release Carrier.

Gongsen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.